Huarong Holdings: terminate the purchase of 100% equity of Xinchao biology and resume trading tomorrow
Financial Associated Press, Dec. 28 - Huarong holdings announced that the counterparty reached an agreement on non employment performance commitment and compensation, terminated the purchase of 100% equity of Shanghai Xinchao Biotechnology Co., Ltd., and the trading of the shares has resumed since the opening of the market on December 29, 2021.
This text is a result of machine translation.
Related companies：
In-depth
Technology
ePropulsion: Pioneering Electric Marine Propulsion for a Sustainable Future
EqualOcean recently had an insightful conversation with Mr. Tao Shizheng, the visionary founder of ePropulsion (Chinese: 逸动科技), we embarked on a journey to understand the essence of the company's profound impact on the electric marine propulsion industry.
Jan 25, 2024 02:24 PM
Jan 30, 2024 07:59 PM
Dec 11, 2023 08:49 PM
Jan 05, 2023 07:33 PM
Nov 16, 2022 05:19 PM
Watson biology: 13 valent pneumococcal polysaccharide conjugate vaccine has been licensed in Morocco
Briefing Dec 12, 2021 05:48 PM
· Healthcare
Watson biology: Yuxi Watson plans to invest in the production and capacity expansion project of polysaccharide conjugate vaccine, with a total investment of 695 million yuan
Briefing Sep 02, 2021 02:06 PM
· Healthcare
Medical stocks continued to decline in the afternoon, with dongfulong falling more than 15%
Technology
AI Technology Provider RealAI Completes New Round of Strategic Financing
According to EqualOcean, recently, AI security infrastructure provider RealAI(瑞莱智慧) announced the completion of a new round of strategic financing, with investors including the Beijing Artificial Intelligence Industry Investment Fund(北京市人工智能产业投资基金).
Yesterday 01:27 PM
Briefing Jul 29, 2021 10:01 AM
Back to Hong Kong, Chinese concept stocks rose collectively, and Wanguo data rose 17.5%
See more
Read next
Insight
In-depth
Insight
In-depth